Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 410

1.

Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial.

Marks WH, Mamode N, Montgomery RA, Stegall MD, Ratner LE, Cornell LD, Rowshani AT, Colvin RB, Dain B, Boice JA, Glotz D; C10-001 Study Group.

Am J Transplant. 2019 Mar 19. doi: 10.1111/ajt.15364. [Epub ahead of print]

PMID:
30887675
2.

Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1/2 clinical trial.

Schiffmann R, Goker-Alpan O, Holida M, Giraldo P, Barisoni L, Colvin RB, Jennette CJ, Maegawa G, Boyadjiev SA, Gonzalez D, Nicholls K, Tuffaha A, Atta MG, Rup B, Charney MR, Paz A, Szlaifer M, Alon S, Brill-Almon E, Chertkoff R, Hughes D.

J Inherit Metab Dis. 2019 May;42(3):534-544. doi: 10.1002/jimd.12080. Epub 2019 Apr 8.

PMID:
30834538
3.

Graft vasculopathy of vascularized composite allografts in humans: a literature review and retrospective study.

Ng ZY, Lellouch AG, Rosales IA, Geoghegan L, Gama AR, Colvin RB, Lantieri LA, Randolph MA, Cetrulo CL Jr.

Transpl Int. 2019 Mar 4. doi: 10.1111/tri.13421. [Epub ahead of print]

PMID:
30829423
4.

Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study.

Germain DP, Nicholls K, Giugliani R, Bichet DG, Hughes DA, Barisoni LM, Colvin RB, Jennette JC, Skuban N, Castelli JP, Benjamin E, Barth JA, Viereck C.

Genet Med. 2019 Feb 6. doi: 10.1038/s41436-019-0451-z. [Epub ahead of print]

PMID:
30723321
5.

Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients.

van der Zwan M, Baan CC, Colvin RB, Smith RN, White RA, Ndishabandi D, Nigg AL, van den Bosch TPP, de Graav GN, Clahsen-van Groningen MC, Hesselink DA.

Transplant Direct. 2018 Dec 20;5(1):e418. doi: 10.1097/TXD.0000000000000857. eCollection 2019 Jan.

6.

Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial.

Schiffmann R, Bichet DG, Jovanovic A, Hughes DA, Giugliani R, Feldt-Rasmussen U, Shankar SP, Barisoni L, Colvin RB, Jennette JC, Holdbrook F, Mulberg A, Castelli JP, Skuban N, Barth JA, Nicholls K.

Orphanet J Rare Dis. 2018 Apr 27;13(1):68. doi: 10.1186/s13023-018-0813-7.

7.

Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices.

Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, D'Agati VD, Ferrario F, Haas M, Jennette JC, Joh K, Nast CC, Noël LH, Rijnink EC, Roberts ISD, Seshan SV, Sethi S, Fogo AB.

Kidney Int. 2018 Apr;93(4):789-796. doi: 10.1016/j.kint.2017.11.023. Epub 2018 Feb 16.

8.

The effects of brain death and ischemia on tolerance induction are organ-specific.

Michel SG, Madariaga MLL, LaMuraglia GM 2nd, Villani V, Sekijima M, Farkash EA, Colvin RB, Sachs DH, Yamada K, Rosengard BR, Allan JS, Madsen JC.

Am J Transplant. 2018 May;18(5):1262-1269. doi: 10.1111/ajt.14674. Epub 2018 Mar 5.

9.

Long-term Nonhuman Primate Renal Allograft Survival Without Ongoing Immunosuppression in Recipients of Delayed Donor Bone Marrow Transplantation.

Hotta K, Oura T, Dehnadi A, Boskovic S, Matsunami M, Rosales I, Smith RN, Colvin RB, Cosimi AB, Kawai T.

Transplantation. 2018 Apr;102(4):e128-e136. doi: 10.1097/TP.0000000000002078.

10.

RNA expression profiling of nonhuman primate renal allograft rejection identifies tolerance.

Smith RN, Matsunami M, Adam BA, Rosales IA, Oura T, Cosimi AB, Kawai T, Mengel M, Colvin RB.

Am J Transplant. 2018 Jun;18(6):1328-1339. doi: 10.1111/ajt.14637. Epub 2018 Feb 17.

11.

RNA expression profiling of renal allografts in a nonhuman primate identifies variation in NK and endothelial gene expression.

Smith RN, Adam BA, Rosales IA, Matsunami M, Oura T, Cosimi AB, Kawai T, Mengel M, Colvin RB.

Am J Transplant. 2018 Jun;18(6):1340-1350. doi: 10.1111/ajt.14639. Epub 2018 Feb 2.

12.

The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.

Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, Nankivell BJ, Halloran PF, Colvin RB, Akalin E, Alachkar N, Bagnasco S, Bouatou Y, Becker JU, Cornell LD, van Huyen JPD, Gibson IW, Kraus ES, Mannon RB, Naesens M, Nickeleit V, Nickerson P, Segev DL, Singh HK, Stegall M, Randhawa P, Racusen L, Solez K, Mengel M.

Am J Transplant. 2018 Feb;18(2):293-307. doi: 10.1111/ajt.14625. Epub 2018 Jan 21.

13.

Both platelets and fibrin deposition are increased in the glomeruli of mice after treatment with Shiga toxin-2.

Kushak RI, Ozaki M, Rosales IA, Boyle DC, Colvin RB, Ingelfinger JR, Stahl GL, Grabowski EF.

Kidney Int. 2017 Dec;92(6):1556-1557. doi: 10.1016/j.kint.2017.09.009. No abstract available.

PMID:
29153141
14.

LDL Receptor-Related Protein 2 (Megalin) as a Target Antigen in Human Kidney Anti-Brush Border Antibody Disease.

Larsen CP, Trivin-Avillach C, Coles P, Collins AB, Merchant M, Ma H, Wilkey DW, Ambruzs JM, Messias NC, Cossey LN, Rosales IA, Wooldridge T, Walker PD, Colvin RB, Klein J, Salant DJ, Beck LH Jr.

J Am Soc Nephrol. 2018 Feb;29(2):644-653. doi: 10.1681/ASN.2017060664. Epub 2017 Oct 26.

15.

Penis Transplantation: First US Experience.

Cetrulo CL Jr, Li K, Salinas HM, Treiser MD, Schol I, Barrisford GW, McGovern FJ, Feldman AS, Grant MT, Tanrikut C, Lee JH, Ehrlichman RJ, Holzer PW, Choy GM, Liu RW, Ng ZY, Lellouch AG, Kurtz JM, Austen WG Jr, Winograd JM, Bojovic B, Eberlin KR, Rosales IA, Colvin RB, Ko DSC.

Ann Surg. 2018 May;267(5):983-988. doi: 10.1097/SLA.0000000000002241.

PMID:
28509699
16.

Prolonged Survival Following Pig-to-Primate Liver Xenotransplantation Utilizing Exogenous Coagulation Factors and Costimulation Blockade.

Shah JA, Patel MS, Elias N, Navarro-Alvarez N, Rosales I, Wilkinson RA, Louras NJ, Hertl M, Fishman JA, Colvin RB, Cosimi AB, Markmann JF, Sachs DH, Vagefi PA.

Am J Transplant. 2017 Aug;17(8):2178-2185. doi: 10.1111/ajt.14341. Epub 2017 Jun 6.

17.

Chronic Antibody-Mediated Rejection in Nonhuman Primate Renal Allografts: Validation of Human Histological and Molecular Phenotypes.

Adam BA, Smith RN, Rosales IA, Matsunami M, Afzali B, Oura T, Cosimi AB, Kawai T, Colvin RB, Mengel M.

Am J Transplant. 2017 Nov;17(11):2841-2850. doi: 10.1111/ajt.14327. Epub 2017 May 24.

18.

A proposal for standardized grading of chronic changes in native kidney biopsy specimens.

Sethi S, D'Agati VD, Nast CC, Fogo AB, De Vriese AS, Markowitz GS, Glassock RJ, Fervenza FC, Seshan SV, Rule A, Racusen LC, Radhakrishnan J, Winearls CG, Appel GB, Bajema IM, Chang A, Colvin RB, Cook HT, Hariharan S, Herrera Hernandez LP, Kambham N, Mengel M, Nath KA, Rennke HG, Ronco P, Rovin BH, Haas M.

Kidney Int. 2017 Apr;91(4):787-789. doi: 10.1016/j.kint.2017.01.002.

PMID:
28314581
19.

Erythropoietin Receptor-Mediated Molecular Crosstalk Promotes T Cell Immunoregulation and Transplant Survival.

Purroy C, Fairchild RL, Tanaka T, Baldwin WM 3rd, Manrique J, Madsen JC, Colvin RB, Alessandrini A, Blazar BR, Fribourg M, Donadei C, Maggiore U, Heeger PS, Cravedi P.

J Am Soc Nephrol. 2017 Aug;28(8):2377-2392. doi: 10.1681/ASN.2016101100. Epub 2017 Mar 16.

20.

The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.

Loupy A, Haas M, Solez K, Racusen L, Glotz D, Seron D, Nankivell BJ, Colvin RB, Afrouzian M, Akalin E, Alachkar N, Bagnasco S, Becker JU, Cornell L, Drachenberg C, Dragun D, de Kort H, Gibson IW, Kraus ES, Lefaucheur C, Legendre C, Liapis H, Muthukumar T, Nickeleit V, Orandi B, Park W, Rabant M, Randhawa P, Reed EF, Roufosse C, Seshan SV, Sis B, Singh HK, Schinstock C, Tambur A, Zeevi A, Mengel M.

Am J Transplant. 2017 Jan;17(1):28-41. doi: 10.1111/ajt.14107.

21.

Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.

Graw JA, Mayeur C, Rosales I, Liu Y, Sabbisetti VS, Riley FE, Rechester O, Malhotra R, Warren HS, Colvin RB, Bonventre JV, Bloch DB, Zapol WM.

Circulation. 2016 Sep 27;134(13):945-60. doi: 10.1161/CIRCULATIONAHA.115.019955. Epub 2016 Aug 11.

22.

Induced regulatory T cells in allograft tolerance via transient mixed chimerism.

Hotta K, Aoyama A, Oura T, Yamada Y, Tonsho M, Huh KH, Kawai K, Schoenfeld D, Allan JS, Madsen JC, Benichou G, Smith RN, Colvin RB, Sachs DH, Cosimi AB, Kawai T.

JCI Insight. 2016 Jul 7;1(10). pii: e86419.

23.

2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.

Demetris AJ, Bellamy C, Hübscher SG, O'Leary J, Randhawa PS, Feng S, Neil D, Colvin RB, McCaughan G, Fung JJ, Del Bello A, Reinholt FP, Haga H, Adeyi O, Czaja AJ, Schiano T, Fiel MI, Smith ML, Sebagh M, Tanigawa RY, Yilmaz F, Alexander G, Baiocchi L, Balasubramanian M, Batal I, Bhan AK, Bucuvalas J, Cerski CTS, Charlotte F, de Vera ME, ElMonayeri M, Fontes P, Furth EE, Gouw ASH, Hafezi-Bakhtiari S, Hart J, Honsova E, Ismail W, Itoh T, Jhala NC, Khettry U, Klintmalm GB, Knechtle S, Koshiba T, Kozlowski T, Lassman CR, Lerut J, Levitsky J, Licini L, Liotta R, Mazariegos G, Minervini MI, Misdraji J, Mohanakumar T, Mölne J, Nasser I, Neuberger J, O'Neil M, Pappo O, Petrovic L, Ruiz P, Sağol Ö, Sanchez Fueyo A, Sasatomi E, Shaked A, Shiller M, Shimizu T, Sis B, Sonzogni A, Stevenson HL, Thung SN, Tisone G, Tsamandas AC, Wernerson A, Wu T, Zeevi A, Zen Y.

Am J Transplant. 2016 Oct;16(10):2816-2835. doi: 10.1111/ajt.13909. Epub 2016 Jul 14.

24.

Prolonged Survival of Pig Skin on Baboons After Administration of Pig Cells Expressing Human CD47.

Tena AA, Sachs DH, Mallard C, Yang YG, Tasaki M, Farkash E, Rosales IA, Colvin RB, Leonard DA, Hawley RJ.

Transplantation. 2017 Feb;101(2):316-321. doi: 10.1097/TP.0000000000001267.

25.

Hydroxyurea for Treatment of Nephrotic Syndrome Associated With Polycythemia Vera.

Hundemer GL, Rosales IA, Chen YB, Colvin RB, Tolkoff-Rubin NE.

Am J Kidney Dis. 2016 Sep;68(3):465-8. doi: 10.1053/j.ajkd.2016.02.056. Epub 2016 Apr 29.

PMID:
27133437
26.

Glomerular disease with idiopathic linear immunoglobulin deposition: a rose by any other name would be atypical.

Rosales IA, Colvin RB.

Kidney Int. 2016 Apr;89(4):750-2. doi: 10.1016/j.kint.2016.01.018.

PMID:
26994573
27.

A Bridge to Somewhere: 25-day Survival After Pig-to-Baboon Liver Xenotransplantation.

Shah JA, Navarro-Alvarez N, DeFazio M, Rosales IA, Elias N, Yeh H, Colvin RB, Cosimi AB, Markmann JF, Hertl M, Sachs DH, Vagefi PA.

Ann Surg. 2016 Jun;263(6):1069-71. doi: 10.1097/SLA.0000000000001659. No abstract available.

PMID:
26825261
28.

Effects of Lung Cotransplantation on Cardiac Allograft Tolerance Across a Full Major Histocompatibility Complex Barrier in Miniature Swine.

Madariaga ML, Spencer PJ, Michel SG, La Muraglia GM 2nd, O'Neil MJ, Mannon EC, Leblang C, Rosales IA, Colvin RB, Sachs DH, Allan JS, Madsen JC.

Am J Transplant. 2016 Mar;16(3):979-86. doi: 10.1111/ajt.13489. Epub 2015 Oct 15.

29.

Immune Complex Tubulointerstitial Nephritis Due to Autoantibodies to the Proximal Tubule Brush Border.

Rosales IA, Collins AB, do Carmo PA, Tolkoff-Rubin N, Smith RN, Colvin RB.

J Am Soc Nephrol. 2016 Feb;27(2):380-4. doi: 10.1681/ASN.2015030334. Epub 2015 Sep 2.

30.

Repeated Injections of IL-2 Break Renal Allograft Tolerance Induced via Mixed Hematopoietic Chimerism in Monkeys.

Yamada Y, Nadazdin O, Boskovic S, Lee S, Zorn E, Smith RN, Colvin RB, Madsen JC, Cosimi AB, Kawai T, Benichou G.

Am J Transplant. 2015 Dec;15(12):3055-66. doi: 10.1111/ajt.13382. Epub 2015 Jul 17.

31.

Tolerance of Lung Allografts Achieved in Nonhuman Primates via Mixed Hematopoietic Chimerism.

Tonsho M, Lee S, Aoyama A, Boskovic S, Nadazdin O, Capetta K, Smith RN, Colvin RB, Sachs DH, Cosimi AB, Kawai T, Madsen JC, Benichou G, Allan JS.

Am J Transplant. 2015 Aug;15(8):2231-9. doi: 10.1111/ajt.13274. Epub 2015 Apr 22.

32.

3-dimensional digital reconstruction of the murine coronary system for the evaluation of chronic allograft vasculopathy.

Fónyad L, Shinoda K, Farkash EA, Groher M, Sebastian DP, Szász AM, Colvin RB, Yagi Y.

Diagn Pathol. 2015 Mar 28;10:16. doi: 10.1186/s13000-015-0248-6.

33.

Kidney-induced cardiac allograft tolerance in miniature swine is dependent on MHC-matching of donor cardiac and renal parenchyma.

Madariaga ML, Michel SG, La Muraglia GM 2nd, Sekijima M, Villani V, Leonard DA, Powell HJ, Kurtz JM, Farkash EA, Colvin RB, Allan JS, Cetrulo CL Jr, Huang CA, Sachs DH, Yamada K, Madsen JC.

Am J Transplant. 2015 Jun;15(6):1580-90. doi: 10.1111/ajt.13131. Epub 2015 Mar 30.

34.

Long-term lung transplantation in nonhuman primates.

Aoyama A, Tonsho M, Ng CY, Lee S, Millington T, Nadazdin O, Wain JC, Cosimi AB, Sachs DH, Smith RN, Colvin RB, Kawai T, Madsen JC, Benichou G, Allan JS.

Am J Transplant. 2015 May;15(5):1415-20. doi: 10.1111/ajt.13130. Epub 2015 Mar 13.

35.

Immunomodulatory Strategies Directed Toward Tolerance of Vascularized Composite Allografts.

Madariaga MLL, Shanmugarajah K, Michel SG, Villani V, Muraglia GM 2nd, Torabi R, Leonard DA, Randolph MA, Colvin RB, Yamada K, Madsen JC, Cetrulo CL Jr, Sachs DH.

Transplantation. 2015 Aug;99(8):1590-1597. doi: 10.1097/TP.0000000000000681.

36.

Recipient-matching of Passenger Leukocytes Prolongs Survival of Donor Lung Allografts in Miniature Swine.

Madariaga ML, Michel SG, La Muraglia GM 2nd, Sihag S, Leonard DA, Farkash EA, Colvin RB, Cetrulo CL Jr, Huang CA, Sachs DH, Madsen JC, Allan JS.

Transplantation. 2015 Jul;99(7):1372-8. doi: 10.1097/TP.0000000000000676.

37.

Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates.

Yamada Y, Ochiai T, Boskovic S, Nadazdin O, Oura T, Schoenfeld D, Cappetta K, Smith RN, Colvin RB, Madsen JC, Sachs DH, Benichou G, Cosimi AB, Kawai T.

Am J Transplant. 2014 Dec;14(12):2704-12. doi: 10.1111/ajt.12936. Epub 2014 Nov 13.

38.

Depletion of T regulatory cells promotes natural killer cell-mediated cardiac allograft vasculopathy.

Hirohashi T, Chase CM, DellaPelle P, Sebastian D, Farkesh E, Colvin RB, Russell PS, Alessandrini A, Madsen JC.

Transplantation. 2014 Oct 27;98(8):828-34. doi: 10.1097/TP.0000000000000329.

39.

Depletion of foxp3(+) T cells abrogates tolerance of skin and heart allografts in murine mixed chimeras without the loss of mixed chimerism.

Shinoda K, Akiyoshi T, Chase CM, Farkash EA, Ndishabandi DK, Raczek CM, Sebastian DP, Pelle PD, Russell PS, Madsen JC, Colvin RB, Alessandrini A.

Am J Transplant. 2014 Oct;14(10):2263-2274. doi: 10.1111/ajt.12851. Epub 2014 Aug 25.

40.

Banff Initiative for Quality Assurance in Transplantation (BIFQUIT): reproducibility of polyomavirus immunohistochemistry in kidney allografts.

Adam B, Randhawa P, Chan S, Zeng G, Regele H, Kushner YB, Colvin RB, Reeve J, Mengel M.

Am J Transplant. 2014 Sep;14(9):2137-47. doi: 10.1111/ajt.12794. Epub 2014 Aug 4.

41.

Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.

Kawai T, Sachs DH, Sprangers B, Spitzer TR, Saidman SL, Zorn E, Tolkoff-Rubin N, Preffer F, Crisalli K, Gao B, Wong W, Morris H, LoCascio SA, Sayre P, Shonts B, Williams WW Jr, Smith RN, Colvin RB, Sykes M, Cosimi AB.

Am J Transplant. 2014 Jul;14(7):1599-611. doi: 10.1111/ajt.12731. Epub 2014 Jun 5.

42.

Banff fibrosis study: multicenter visual assessment and computerized analysis of interstitial fibrosis in kidney biopsies.

Farris AB, Chan S, Climenhaga J, Adam B, Bellamy CO, Serón D, Colvin RB, Reeve J, Mengel M.

Am J Transplant. 2014 Apr;14(4):897-907. doi: 10.1111/ajt.12641. Epub 2014 Feb 20.

43.

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.

Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD, Wallace WD, Mengel M; Banff meeting report writing committee.

Am J Transplant. 2014 Feb;14(2):272-83. doi: 10.1111/ajt.12590. Erratum in: Am J Transplant. 2015 Oct;15(10):2784. Rangel, Erika [corrected to Rangel, Erika B].

44.

Granulomatous interstitial nephritis as a manifestation of Crohn disease.

Colvin RB, Traum AZ, Taheri D, Jafari M, Dolatkhah S.

Arch Pathol Lab Med. 2014 Jan;138(1):125-7. doi: 10.5858/arpa.2012-0224-CR.

PMID:
24377821
45.

Polyreactive antibodies developing amidst humoral rejection of human kidney grafts bind apoptotic cells and activate complement.

Porcheray F, Fraser JW, Gao B, McColl A, DeVito J, Dargon I, Helou Y, Wong W, Girouard TC, Saidman SL, Colvin RB, Palmisano A, Maggiore U, Vaglio A, Smith RN, Zorn E.

Am J Transplant. 2013 Oct;13(10):2590-600. doi: 10.1111/ajt.12394. Epub 2013 Aug 6.

46.

Transitional cell carcinoma arising within a pediatric donor renal transplant in association with BK nephropathy.

McDaid J, Farkash EA, Steele DJ, Martins PN, Kotton CN, Elias N, Ko DS, Colvin RB, Hertl M.

Transplantation. 2013 Mar 15;95(5):e28-30. doi: 10.1097/TP.0b013e31828235ec. No abstract available.

PMID:
23503509
47.

Banff initiative for quality assurance in transplantation (BIFQUIT): reproducibility of C4d immunohistochemistry in kidney allografts.

Mengel M, Chan S, Climenhaga J, Kushner YB, Regele H, Colvin RB, Randhawa P.

Am J Transplant. 2013 May;13(5):1235-45. doi: 10.1111/ajt.12193. Epub 2013 Mar 6.

48.

Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.

Tait BD, Süsal C, Gebel HM, Nickerson PW, Zachary AA, Claas FH, Reed EF, Bray RA, Campbell P, Chapman JR, Coates PT, Colvin RB, Cozzi E, Doxiadis II, Fuggle SV, Gill J, Glotz D, Lachmann N, Mohanakumar T, Suciu-Foca N, Sumitran-Holgersson S, Tanabe K, Taylor CJ, Tyan DB, Webster A, Zeevi A, Opelz G.

Transplantation. 2013 Jan 15;95(1):19-47. doi: 10.1097/TP.0b013e31827a19cc.

PMID:
23238534
49.

Role of complement and NK cells in antibody mediated rejection.

Akiyoshi T, Hirohashi T, Alessandrini A, Chase CM, Farkash EA, Neal Smith R, Madsen JC, Russell PS, Colvin RB.

Hum Immunol. 2012 Dec;73(12):1226-32. doi: 10.1016/j.humimm.2012.07.330. Epub 2012 Jul 28. Review.

50.

Pathology after eculizumab in dense deposit disease and C3 GN.

Herlitz LC, Bomback AS, Markowitz GS, Stokes MB, Smith RN, Colvin RB, Appel GB, D'Agati VD.

J Am Soc Nephrol. 2012 Jul;23(7):1229-37. doi: 10.1681/ASN.2011121186. Epub 2012 Jun 7.

Supplemental Content

Loading ...
Support Center